Showing 961 - 980 results of 235,177 for search '(( 2 e decrease ) OR ( 10 ((((we decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 2.21s Refine Results
  1. 961
  2. 962
  3. 963
  4. 964
  5. 965
  6. 966

    WNT3 decreases GCP proliferation by inhibiting SHH dependent gene transcription. by Sandrine L. Anne (489755)

    Published 2013
    “…(<i>D</i>) WNT3 decreased Gli1, and <i>Ptch1</i> mRNA levels after 6 h of treatment (Con=1; WNT3: Gli1=0.56±0.10, Gli2=0.90±0.10, Mycn= 0.99±0.05, <i>Ptch1</i>=0.58±0.09, and <i>Ccnd1</i>=0.89±0.09). …”
  7. 967
  8. 968

    Fibrinogen decreases cardiomyocyte contractility through an ICAM-1-dependent mechanism-0 by John H Boyd (88940)

    Published 2011
    “…Acquired with group mean data, the curves demonstrate an LPS-induced increased end diastolic volume (EDV), maintenance of stroke volume (SV), and therefore a marked reduction of left ventricular ejection fraction (SV/EDV). E, end-systolic elastance.<p><b>Copyright information:</b></p><p>Taken from "Fibrinogen decreases cardiomyocyte contractility through an ICAM-1-dependent mechanism"</p><p>http://ccforum.com/content/12/1/R2</p><p>Critical Care 2008;12(1):R2-R2.…”
  9. 969

    Fibrinogen decreases cardiomyocyte contractility through an ICAM-1-dependent mechanism-8 by John H Boyd (88940)

    Published 2011
    “…Acquired with group mean data, the curves demonstrate an LPS-induced increased end diastolic volume (EDV), maintenance of stroke volume (SV), and therefore a marked reduction of left ventricular ejection fraction (SV/EDV). E, end-systolic elastance.<p><b>Copyright information:</b></p><p>Taken from "Fibrinogen decreases cardiomyocyte contractility through an ICAM-1-dependent mechanism"</p><p>http://ccforum.com/content/12/1/R2</p><p>Critical Care 2008;12(1):R2-R2.…”
  10. 970
  11. 971
  12. 972

    LNAME and TEMPOL restored α-actin and decreased MMPs at the BT of ligated animals. by Nicholas Liaw (592158)

    Published 2014
    “…MMP-2 staining increased at the BT following ligation (G) compared to the sham surgery group (F), and was decreased with either LNAME (H) or TEMPOL (I) treatment. …”
  13. 973
  14. 974
  15. 975
  16. 976
  17. 977
  18. 978
  19. 979
  20. 980